Centene (CNC) Competitors $27.95 -1.19 (-4.08%) Closing price 03:59 PM EasternExtended Trading$27.94 0.00 (-0.02%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, MOH, SEM, HUM, UNH, CI, JYNT, AEMD, COR, and BDXShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Humana (HUM), UnitedHealth Group (UNH), Cigna Group (CI), Joint (JYNT), Aethlon Medical (AEMD), Cencora (COR), and Becton, Dickinson and Company (BDX). These companies are all part of the "medical" sector. Centene vs. Its Competitors Elevance Health Molina Healthcare Select Medical Humana UnitedHealth Group Cigna Group Joint Aethlon Medical Cencora Becton, Dickinson and Company Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends. Do analysts rate CNC or ELV? Centene currently has a consensus price target of $58.63, indicating a potential upside of 109.75%. Elevance Health has a consensus price target of $435.93, indicating a potential upside of 57.45%. Given Centene's higher probable upside, equities research analysts plainly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 1 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.28Elevance Health 0 Sell rating(s) 4 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media prefer CNC or ELV? In the previous week, Centene had 6 more articles in the media than Elevance Health. MarketBeat recorded 84 mentions for Centene and 78 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.56 beat Centene's score of 0.07 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 8 Very Positive mention(s) 7 Positive mention(s) 53 Neutral mention(s) 12 Negative mention(s) 1 Very Negative mention(s) Neutral Elevance Health 36 Very Positive mention(s) 6 Positive mention(s) 16 Neutral mention(s) 8 Negative mention(s) 2 Very Negative mention(s) Positive Is CNC or ELV more profitable? Elevance Health has a net margin of 2.83% compared to Centene's net margin of 2.04%. Elevance Health's return on equity of 17.59% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene2.04% 14.56% 4.75% Elevance Health 2.83%17.59%6.36% Which has higher earnings and valuation, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$163.07B0.09$3.31B$6.714.17Elevance Health$177.01B0.35$5.98B$25.6310.80 Which has more risk & volatility, CNC or ELV? Centene has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Do insiders & institutionals have more ownership in CNC or ELV? 93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of Centene shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryElevance Health beats Centene on 12 of the 16 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneMED IndustryMedical SectorNYSE ExchangeMarket Cap$14.50B$39.56B$5.54B$20.85BDividend YieldN/A55.01%3.75%3.65%P/E Ratio4.178.4328.0127.55Price / Sales0.091.39433.8159.20Price / Cash2.948.5936.1622.29Price / Book0.532.518.124.66Net Income$3.31B$2.64B$3.25B$994.58M7 Day Performance-11.04%-4.08%0.97%-0.29%1 Month Performance-49.26%-15.20%7.36%4.91%1 Year Performance-57.45%-38.24%31.31%10.53% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9693 of 5 stars$27.95-4.1%$58.63+109.7%-57.0%$14.50B$163.07B4.1760,500Trending NewsUpcoming EarningsAnalyst ForecastHigh Trading VolumeELVElevance Health4.9753 of 5 stars$339.77-0.3%$491.07+44.5%-42.1%$76.77B$177.01B13.26104,200Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastInsider TradeGap DownMOHMolina Healthcare4.9918 of 5 stars$219.08-1.1%$352.21+60.8%-31.5%$11.87B$41.87B10.5818,000Trending NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionSEMSelect Medical5 of 5 stars$14.91+1.2%$26.00+74.3%-62.3%$1.92B$5.22B11.1344,100News CoverageHUMHumana4.8788 of 5 stars$227.13-1.5%$280.76+23.6%-44.3%$27.41B$117.76B16.0665,680Trending NewsAnalyst ForecastUNHUnitedHealth Group4.9963 of 5 stars$300.37-1.2%$415.00+38.2%-49.8%$272.48B$410.06B12.58400,000Trending NewsAnalyst ForecastAnalyst RevisionCICigna Group4.9985 of 5 stars$302.92-0.1%$380.39+25.6%-13.5%$80.92B$247.12B16.7773,500Positive NewsJYNTJoint3.6092 of 5 stars$11.45-1.3%$15.50+35.4%-22.7%$175.19M$51.90M-19.74320Positive NewsAEMDAethlon Medical1.8887 of 5 stars$1.15-2.5%$56.00+4,769.6%-63.9%$2.97MN/A-0.0910CORCencora4.4816 of 5 stars$297.00+0.6%$306.33+3.1%+30.8%$57.57B$638.56M34.4546,000Positive NewsAnalyst ForecastBDXBecton, Dickinson and Company4.7555 of 5 stars$177.15+0.7%$219.22+23.7%-22.8%$50.77B$20.87B33.8174,000Analyst RevisionHigh Trading Volume Related Companies and Tools Related Companies ELV Alternatives MOH Alternatives SEM Alternatives HUM Alternatives UNH Alternatives CI Alternatives JYNT Alternatives AEMD Alternatives COR Alternatives BDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
